We have demonstrated that BCL9 in a protein complex with STAT3 drives DCIS invasive progression by regulation of enhancers and enhancer associated target genes involved in cellular growth, invasion and migration. This evidence concerns the gene STAT3 and ductal breast carcinoma in situ.